Britain's AstraZeneca to buy 9.8 percent stake in France's Innate Pharma

British drugmaker AstraZeneca will buy a newly issued equity stake of 9.8 percent in smaller French peer Innate Pharma, as consolidation intensifies in the healthcare sector.

from Reuters: Health News https://reut.rs/2AnL0W5